Strength Repair & Recovery BPC-157 BPC-157 is a stable synthetic pentadecapeptide derived from a gastric protein, widely studied in tissue-repair research
Palmieri F: Diseases caused by defects of mitochondrial carriers: a review
For DOACs, dabigatran, edoxaban, and betrixaban have the fewest drug-drug interactions, followed by apixaban and rivaroxaban
a 2021 meta-analysis examining the differences between once- and twice-daily dosing of DOACs reported that there was no significant difference between the different drugs in terms of major thrombotic events or major bleeding risks
A phase I trial determined that 2-DG combined with docetaxel at 63 mg/kg/day is clinically tolerable, showing manageable toxicity and modest antitumor activity (177)
Liposomal glutathione has proven to be an effective method of delivering stable glutathione into the body tissues